<DOC>
<DOCNO>
EP-0002258
</DOCNO>
<TEXT>
<DATE>
19790613
</DATE>
<IPC-CLASSIFICATIONS>
C07D-233/00 <main>C07D-233/76</main> A61K-31/41 C07D-233/76 A61P-7/00 C07D-233/72 A61K-31/4166 C07D-233/78 C07D-403/06 A61K-31/4164 A61K-31/415 
</IPC-CLASSIFICATIONS>
<TITLE>
hydantoin derivatives and salts thereof, their synthesis and intermediates, and pharmaceutical formulations.
</TITLE>
<APPLICANT>
wellcome foundgb<sep>the wellcome foundation limited<sep>the wellcome foundation limitedunicorn house 160 euston road p.o. box 129london nw1 2bpgb<sep>the wellcome foundation limited <sep>
</APPLICANT>
<INVENTOR>
caldwell albert gordon<sep>whittaker norman<sep>caldwell, albert gordon<sep>whittaker, norman<sep>caldwell, albert gordon119 gates green roadwest wickham kentgb<sep>whittaker, norman37 brabourne risebeckenham kentgb<sep>caldwell, albert gordon <sep>whittaker, norman<sep>caldwell, albert gordon119 gates green roadwest wickham kentgb<sep>whittaker, norman37 brabourne risebeckenham kentgb<sep>
</INVENTOR>
<ABSTRACT>
the invention relates to new hydantoin derivatives with  pharmacological properties related to those of natural  prostaglandins, intermediates therein, compositions containing  the said derivatives, and their use in medicine.  in  particular, certain compounds have been found to be potent  mimetics of the anti-platelet aggregatory properties of  prostaglandin e‚ÇÅ.  
</ABSTRACT>
</TEXT>
</DOC>
